Serum FGF-19 levels were higher in relation to the size of the tumour, the presence of portal vein thrombosis, jaundice, lower limb oedema, and weight loss; however, these differences did not reach statistical significance (Table 4 ).
← all excerpts
Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma.
1
—
—